Citation Impact
Citing Papers
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis
2011
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
2010
Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
2010
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Optical control of insulin release using a photoswitchable sulfonylurea
2014
Preventive therapy for breast cancer: a consensus statement
2011
Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice
2011
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy
2012
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
2012
Cytokines in inflammatory bowel disease
2014 Standout
Pharmacotherapy of type 2 diabetes: An update
2017
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
2012
Bowel Disorders
2016 Standout
Severe Hypoglycemia and Risks of Vascular Events and Death
2010 Standout
Ulcerative Colitis
2011 Standout
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
2010
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis
2011
Hallmarks of aging: An expanding universe
2023 Standout
Rapamycin: One Drug, Many Effects
2014 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
2011
The mechanisms of action of metformin
2017 Standout
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
2011
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
2013
Insulin analogues and cancer risk: cause for concern orcause célèbre?
2010
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
2010
The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern
2011
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Diabetes and cancer
2009
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
2017 Standout
Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?
2010
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
2012
Differential effects of metformin on age related comorbidities in older men with type 2 diabetes
2017
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Molecular mechanisms of cancer development in obesity
2011
The quest to slow ageing through drug discovery
2020
Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up
2012
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
What We Talk About When We Talk About Fat
2014 Standout
Revised Estimates for the Number of Human and Bacteria Cells in the Body
2016 Standout
The maternal womb
2011
Epidemiological aspects of neoplasms in diabetes
2010
Type 2 diabetes mellitus
2015 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Cancer-related inflammation
2008 StandoutNature
Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?
2011
Rapamycin passes the torch: a new generation of mTOR inhibitors
2011
ROS signalling in the biology of cancer
2017 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
2010
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
External Validation of the UKPDS Risk Engine in Incident Type 2 Diabetes: A Need for New Type 2 Diabetes–Specific Risk Equations
2013
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non‐diabetic controls
2014
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Fundamentals of cancer metabolism
2016 Standout
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes
2009
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
2017
Impact of Diabetes Mellitus and Insulin Use on Survival After Colorectal Cancer Diagnosis: The Cancer Prevention Study-II Nutrition Cohort
2011
Diabetes and Cancer
2010 Standout
International Diabetes Center Treatment of Type 2 Diabetes Glucose Algorithm
2011
Quantification and variability in colonic volume with a novel magnetic resonance imaging method
2015
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
2009
Ciprofloxacin–Photoswitch Conjugates: A Facile Strategy for Photopharmacology
2015 StandoutNobel
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone
2011
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Controlling the activity of quorum sensing autoinducers with light
2015 StandoutNobel
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
2016
Pioglitazone and Bladder Cancer
2011
Nonalcoholic Fatty Liver Disease
2015 Standout
Effects of Sulfonylureas on Tumor Growth: A Review of the Literature
2013
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
Lipotoxicity disrupts incretin-regulated human β cell connectivity
2013
Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
2013
Works of C Poole being referenced
Insulin therapy in diabetes and cancer risk: Current understanding and implications for future study
2011
Quality of Life Improvements Attributed to Combination Therapy with Oral and Topical Mesalazine in Mild-to-Moderately Active Ulcerative Colitis
2009
Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*
2010
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
2009